PT-141 10mg
Synthetic melanocortin peptide studied for MC receptor signaling and neuroendocrine pathway activity in laboratory research models.
Compound Overview
PT-141, also known as Bremelanotide, is a synthetic peptide analogue derived from melanocyte-stimulating hormone (MSH). It is studied in laboratory environments for its interaction with melanocortin receptors, particularly MC3R and MC4R, which are involved in neuroendocrine signaling pathways within the central nervous system.
In experimental research models, PT-141 is frequently evaluated for receptor-binding dynamics and signaling activity within melanocortin systems. Studies commonly investigate neural signaling pathways, receptor-mediated communication within the hypothalamus, and broader neuroendocrine regulatory networks influenced by melanocortin receptor activation.
Melanocortin Receptor Research
Studied for activation of melanocortin receptors involved in central nervous system signaling pathways.
Neuroendocrine Pathway Studies
Frequently evaluated in laboratory models examining receptor-mediated communication and hypothalamic signaling networks.
Laboratory Classification
Classified as a melanocortin receptor agonist peptide for experimental and analytical neuroendocrine research.
Product Specifications
- Product Name: PT-141
- Alternative Name: Bremelanotide
- Peptide Type: Melanocortin analogue
- Primary Targets: MC3R and MC4R receptors
- Quantity: 10mg per vial
- Form: Lyophilized peptide powder
- Intended Use: Research use only
Be the first to review “PT-141 10MG”
Related products
Reviews
There are no reviews yet.